Passoni P - Search Results

1

Internal target volume defined by contrast-enhanced 4D-CT scan in unresectable pancreatic tumour: evaluation and reproducibility.

Cattaneo GM, Passoni P, Sangalli G, Slim N, Longobardi B, Mancosu P, Bettinardi V, Di Muzio N, Calandrino R. Cattaneo GM, et al. Among authors: passoni p. Radiother Oncol. 2010 Dec;97(3):525-9. doi: 10.1016/j.radonc.2010.08.007. Epub 2010 Sep 7. Radiother Oncol. 2010. PMID: 20826027

2

Effect on local control and survival of electron beam intraoperative irradiation for resectable pancreatic adenocarcinoma.

Reni M, Panucci MG, Ferreri AJ, Balzano G, Passoni P, Cattaneo GM, Cordio S, Scaglietti U, Zerbi A, Ceresoli GL, Fiorino C, Calandrino R, Staudacher C, Villa E, Di Carlo V. Reni M, et al. Among authors: passoni p. Int J Radiat Oncol Biol Phys. 2001 Jul 1;50(3):651-8. doi: 10.1016/s0360-3016(01)01470-5. Int J Radiat Oncol Biol Phys. 2001. PMID: 11395232 Clinical Trial.

3

Target delineation in post-operative radiotherapy of brain gliomas: interobserver variability and impact of image registration of MR(pre-operative) images on treatment planning CT scans.

Cattaneo GM, Reni M, Rizzo G, Castellone P, Ceresoli GL, Cozzarini C, Ferreri AJ, Passoni P, Calandrino R. Cattaneo GM, et al. Among authors: passoni p. Radiother Oncol. 2005 May;75(2):217-23. doi: 10.1016/j.radonc.2005.03.012. Radiother Oncol. 2005. PMID: 15885831

4

Contrast enhanced 4D-CT imaging for target volume definition in pancreatic ductal adenocarcinoma.

Mancosu P, Bettinardi V, Passoni P, Gusmini S, Cappio S, Gilardi MC, Cattaneo GM, Reni M, Del Maschio A, Di Muzio N, Fazio F. Mancosu P, et al. Among authors: passoni p. Radiother Oncol. 2008 Jun;87(3):339-42. doi: 10.1016/j.radonc.2008.04.007. Epub 2008 May 15. Radiother Oncol. 2008. PMID: 18486253

5

Planning design of locally advanced pancreatic carcinoma using 4DCT and IMRT/IGRT technologies.

Sangalli G, Passoni P, Cattaneo GM, Broggi S, Bettinardi V, Reni M, Slim N, Muzio ND, Calandrino R. Sangalli G, et al. Among authors: passoni p. Acta Oncol. 2011 Jan;50(1):72-80. doi: 10.3109/0284186X.2010.484425. Epub 2010 May 18. Acta Oncol. 2011. PMID: 20482224 Clinical Trial.

6

A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel (PEXG or PDXG regimen).

Reni M, Cereda S, Rognone A, Belli C, Ghidini M, Longoni S, Fugazza C, Rezzonico S, Passoni P, Slim N, Balzano G, Nicoletti R, Cappio S, Doglioni C, Villa E. Reni M, et al. Among authors: passoni p. Cancer Chemother Pharmacol. 2012 Jan;69(1):115-23. doi: 10.1007/s00280-011-1680-2. Epub 2011 May 28. Cancer Chemother Pharmacol. 2012. PMID: 21626049 Clinical Trial.

7

Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or gemcitabine followed by chemoradiation in pancreatic cancer: a randomized phase II trial.

Reni M, Balzano G, Aprile G, Cereda S, Passoni P, Zerbi A, Tronconi MC, Milandri C, Saletti P, Rognone A, Fugazza C, Magli A, Di Muzio N, Di Carlo V, Villa E. Reni M, et al. Among authors: passoni p. Ann Surg Oncol. 2012 Jul;19(7):2256-63. doi: 10.1245/s10434-011-2205-2. Epub 2012 Jan 12. Ann Surg Oncol. 2012. PMID: 22237835 Clinical Trial.

8

Characterisation of rectal motion during neo-adjuvant radiochemotherapy for rectal cancer with image-guided tomotherapy: implications for adaptive dose escalation strategies.

Maggiulli E, Fiorino C, Passoni P, Broggi S, Gianolini S, Salvetti C, Slim N, Di Muzio NG, Calandrino R. Maggiulli E, et al. Among authors: passoni p. Acta Oncol. 2012 Mar;51(3):318-24. doi: 10.3109/0284186X.2012.666358. Acta Oncol. 2012. PMID: 22497434 Clinical Trial.

9

Role of PET/CT in the clinical management of locally advanced pancreatic cancer.

Picchio M, Giovannini E, Passoni P, Busnardo E, Landoni C, Giovacchini G, Bettinardi V, Crivellaro C, Gianolli L, Di Muzio N, Messa C. Picchio M, et al. Among authors: passoni p. Tumori. 2012 Sep-Oct;98(5):643-51. doi: 10.1177/030089161209800516. Tumori. 2012. PMID: 23235761

10

Dosimetric and clinical predictors of toxicity following combined chemotherapy and moderately hypofractionated rotational radiotherapy of locally advanced pancreatic adenocarcinoma.

Cattaneo GM, Passoni P, Longobardi B, Slim N, Reni M, Cereda S, di Muzio N, Calandrino R. Cattaneo GM, et al. Among authors: passoni p. Radiother Oncol. 2013 Jul;108(1):66-71. doi: 10.1016/j.radonc.2013.05.011. Epub 2013 May 30. Radiother Oncol. 2013. PMID: 23726116

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

77 results

Search Page